ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
| Gross profit (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $26.4B | +9.2% | 5.0% | 7.9% |
| Gross profit (TTM) | $26.4B |
|---|---|
| YoY | +9.2% |
| 5-year CAGR | 5.0% |
| 10-year CAGR | 7.9% |
Gross profit
| Period | Gross profit | YoY |
|---|---|---|
| 2025 | $25.0B | +7.6% |
| 2024 | $23.2B | +5.0% |
| 2023 | $22.1B | −9.7% |
| 2022 | $24.5B | −0.1% |
| 2021 | $24.5B | +25.2% |
| 2020 | $19.6B | +5.0% |
| 2019 | $18.7B | +4.5% |
| 2018 | $17.9B | +19.3% |
| 2017 | $15.0B | +27.4% |
| 2016 | $11.8B | +0.9% |
| 2015 | $11.7B | +5.7% |
| 2014 | $11.0B | +5.4% |
| 2013 | $10.5B | +3.1% |
| 2012 | $10.2B | −10.9% |
| 2011 | $11.4B | −44.4% |
| 2010 | $20.5B | +16.8% |
| 2009 | $17.6B | +3.8% |
| 2008 | $16.9B | +16.7% |
| 2007 | $14.5B | — |